Cleerly is an AI-based digital care platform for the diagnosis of heart disease. It utilizes coronary computed tomography angiography (CCTA) to provide analyses of atherosclerosis, plaque buildup and stenosis, through machine learning algorithms. The technology creates 3D models of coronary arteries for early heart disease detection and treatment plans. It includes the Cleerly Proxy and Cleerly ISCHEMIA for coronary artery disease.

Envisionit Deep AI develops AI-driven radiology solutions, including RADIFY for automated image analysis and RATify for real-time AI model monitoring. Their tools are designed to assist radiologists with triaging and diagnostic support, particularly for critical conditions like pneumothorax and pleural effusion. The platform supports applications in teleradiology, training, and research, aiming to enhance diagnostic accuracy and accessibility.

HeartFlow offers a non-invasive diagnostic tool for coronary artery disease (CAD) called the HeartFlow FFRCT Analysis. This technology utilizes data from coronary computed tomography angiography (CCTA) scans to create a personalized, color-coded 3D model of a patient's coronary arteries. By applying advanced algorithms and computational fluid dynamics, it assesses the impact of arterial blockages on blood flow, aiding physicians in determining the necessity of interventions like stenting or bypass surgery.